<DOC>
	<DOC>NCT02357849</DOC>
	<brief_summary>We are conducting a randomized, 24-week, double-blind study, comparing fluoxetine with aripiprazole in 48 patients with attenuated positive symptoms at a level of at least moderate severity.</brief_summary>
	<brief_title>Fluoxetine vs Aripiprazole Comparative Trial (FACT)</brief_title>
	<detailed_description>To Compare Fluoxetine and Aripiprazole on All-cause Discontinuation/Need to Add Another Psychiatric Medication, Symptomatic Improvement, and Adverse Effects</detailed_description>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Fluoxetine</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>consent obtained from patients and their parents (assent for patients under 18); age 1225 years (inclusive); Englishspeaking; at least one positive (Scale A) SOPS score of 35, i.e., moderate, moderately severe or severe. lifetime diagnosis of an Axis I psychotic disorder, including: schizophreniform disorder, schizophrenia, schizoaffective disorder, bipolar disorder, or major depression with psychotic features; current psychosis (any positive symptom SOPS score of 6, i.e., extreme); current diagnosis of Major Depressive Disorder, single episode or recurrent, severe without psychotic features; current stimulant treatment; history of neurological, neuroendocrine or other medical condition known to affect the brain; any significant medical condition that contraindicates treatment with either aripiprazole or fluoxetine; past or current substance dependence; sunstance abuse within the last 4 weeks; IQ &lt; 70.</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>